We are pleased to announce the opening of our AllBright US office.

AllBright lawyers as legal counsel advising global healthcare giant Grifols for the incorporation of plasma collection companies jointly with Boya

Allbright assists CF Pharm Tech, Inc. in completing RMB 440 million D-round financing

In August, 2017, CF PharmTech, Inc. successfully completed the D-round financing in amount of RMB 440 million.

AllBright Advised Ceva, a French Company, in Completing the Acquisition of a Well-Known Animal Vaccine Manufacturer in China

AllBright advises Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on its 2015 private placement of A Shares

AllBright advises A2H Technology (Wuhan) Co., Ltd on its listing on NSX

AllBright Advises Zhenhua Steel on its Listing on the National Equities Exchange and Quotations

AllBright Advises Sanjiangyuan Ophiocordyceps Sinensis on Listing on the National Equities Exchange and Quotations

AllBright Advises HighLight Capital on A-round Investment in JUVA MEDTECH

AllBright Advises South Pharmaceutical on Listing on National Equities Exchange and Quotations